Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.
Samantha E GreenbergSaundra S BuysSandra L EdwardsWhitney EspinelAlison FraserAmanda GammonBrent HafenKimberly A HergetWendy KohlmannCamille RoundyCarol SweeneyPublished in: Cancer medicine (2019)
This study quantifies the population-based prevalence of HBOC criteria using objectively determined genealogy and cancer incidence data. Sporadic breast cancer likely represents a portion of the high prevalence of family cancer history seen in this study. These results underline the importance of establishing presence of a deleterious mutation in an affected family member, per NCCN guidelines, before testing unaffected relatives.